er logo points to home page Home page Search Glossary Search Links Database Sitemap Contact Expert Reviews in Molecular Medicine
Reprint version of article Features associated with the article       Register interest

Expert Reviews in Molecular Medicine: http://www.expertreviews.org/
Accession information: Vol. 8; Issue 14; 20 June 2006 Abstract
PDF

Model for pathogenesis of alopecia areata

Wei Lu, Jerry Shapiro, Mei Yu, Armin Barekatain, Blanche Lo, Andreas Finner and Kevin McElwee

Author contact details

Figure 2. Model for pathogenesis of alopecia areata. The apparent immune-privileged status of anagen-stage hair follicles is thought to break down during AA, thereby exposing normally sequestered hair-follicle-specific antigens. Activated antigen-presenting cells (APCs) capture and process hair follicle antigens and present them in the context of major histocompatibility complex (MHC) class I and II. Antigen presentation, in association with costimulation and pro-inflammatory cyctokines, promotes the activation and proliferation of pathogenic, autoreactive T cells. T cells migrate to the skin and infiltrate around anagen-stage hair follicles, where a chemotactic stimulus is present. Peri-follicular inflammation disrupts hair follicle keratinocyte cells through cytokines whereas intrafollicular penetration enables cell–cell contact disruption of hair growth. The initial inflammation event increases hair follicle dystrophy and promotes continued pathogenic cell recruitment to perpetuate the autoimmune disease cycle. Hair follicles in a dystrophic state respond by truncating anagen and entering a telogen state. Any attempt to re-enter a new anagen growth phase is met with a renewed inflammatory response. Abbreviations: B, B cell; Tc, T cytotoxic cell; Th, T helper cell.

| home | search | glossary | links | sitemap | contact |

Expert Reviews in Molecular Medicine © Cambridge University Press ISSN 1462-3994 (Disclaimer and copyright)
Editorial Office: Centre for Applied Research in Educational Technologies (CARET), 1st Floor, 16 Mill Lane, Cambridge, CB2 1SB, UK. Tel: +44 (0)1223 765 375; Fax: +44(0)1223 765 505; E-mail: ermm@caret.cam.ac.uk